Skip to NavigationSkip to content

Pharmafile - Research and Development News

Idorsia has announced that it has submitted a new drug application (NDA) to the FDA in hopes of gaining approval for aprocitentan; its novel and...
AlzeCure, a pharma company who focuses on its portfolio of small molecule candidate drugs for central nervous system (CNS) diseases, working on both...
The University of Plymouth has co-authored a new study, published in The Lancet, which shows how an asthma drug, commercially known as Relvar Ellipta...
The FDA has approved Cytalux (pafolacianine) to be used in lung cancer surgery: the targeted imaging agent binds to cancerous tissues, glowing under...
The Center for Disease Control and Prevention (CDC) has given researchers at Washington University School of Medicine in St Louis, US a $12.5m grant...
Biotech company Guardant Health has announced that its blood test-based cancer screening technique appears to be effective: the liquid biopsy...
Merck & Co and Moderna have partnered to utilise the mRNA technology used to combat COVID-19, however this time the technology is set to be used...
California, US-based ClearPoint Neuro has recruited the first patient in a clinical trial which will use ClearPoint’s Prism Neuro Laser Therapy...
A recently-developed AI model has been shown to predict ten-year incidences with a similar level of success to the current standard of care. The AI...
Autolus Therapeutic, a clinical-stage biopharmaceutical company, has announced that the phase 2 FELIX clinical trial of obecabtagene autoleucel (obe-...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches